The Liver Week 2020 Virtual Conference [DAY 1: Thursday, August 13, 2020]
- 08:40-09:00
- The Liver Week 2020 Opening Ceremony
- 09:00-09:05
- ISALPDC Opening Ceremony
- 09:00-10:10
Real Time Discussion
KASL Symposium 1. Up-to-Date Treatment for Liver Diseases- Dong Joon Kim (Hallym Univ.), Joo Hyun Sohn (Hanyang Univ.)
- 09:00-09:20
- Pharmacological Treatment of Alcoholic HepatitisGyongyi Szabo (Harvard Univ., USA)
- 09:20-09:40
- Pharmacological Treatment of Nonalcoholic SteatohepatitisManal Abdelmalek (Duke Univ., USA)
- 09:40-10:00
- New Horizon of Immuno-Oncologic TherapyAmit Singal (Univ. of Texas Southwestern, USA)
- 10:00-10:10
- Discussion
- 09:00-10:10
- PG1. Current Issues in Chronic Hepatitis B
- 09:00-09:10
- Case Presentation and Key QuestionsHyun Woong Lee (Yonsei Univ.)
- 09:10-09:30
- Immune Tolerant Chronic Hepatitis B: To Treat or Not?Jonggi Choi (Univ. of Ulsan)
- 09:30-09:50
- Risks and Benefits of Antiviral Therapy During PregnancyYoung-Sun Lee (Korea Univ.)
- 09:50-10:10
- Prophylactic Antiviral Therapy for Hepatitis B During Immunosuppressive TherapyIn Hee Kim (Chonbuk National Univ.)
- 09:05-11:00
Real Time Discussion
ISALPDC 1. Obesity-Alcohol Synergism- Won-IL Jeong (KAIST), Kenichi Ikejima (Juntendo Univ., Japan)
- 09:05-09:25
- Obesity and Alcohol Are Deadly Combination to Induce SteatohepatitisBin Gao (National Institutes of Health, USA)
- 09:25-09:45
- Alcohol-NAFLD InteractionsKenichi Ikejima (Juntendo Univ., Japan)
- 09:45-10:05
- Autophagy Regulation in Alcoholic and Non-Alcoholic Liver SteatosisSang Geon Kim (Seoul National Univ.)
- 10:05-10:25
- Alcohol-NAFLD Interactions in a Large Korean Cohort StudyYong Kyun Cho (Sungkyunkwan Univ.)
- 10:25-10:35
- Interaction between CD40L and CD40 Mediates Hepatic Exosomal Delivery to Kupffer Cells in Alcoholic Liver DiseaseKyurae Kim (KAIST)
- 10:35-10:45
- The Effect of Intestinal Flora Modification on Alcoholic Liver Injury in Obese KK-Ay MiceKazuyoshi Kon (Juntendo Univ., Japan)
- 10:45-11:00
- Round Table Discussions
- 10:20-11:20
Real Time Discussion
Plenary Presentation 1- Kwan Sik Lee (Yonsei Univ.), Kwan Soo Byun (Korea Univ.), Ho Seong Han (Seoul National Univ.)
- 11:00-13:00
Real Time Discussion
ISALPDC 2. Novel Cellular and Organ Crosstalk in Alcoholic Liver Disease- Bin Gao (National Institutes of Health, USA ), Yasuko Iwakiri (Yale Univ., USA)
- 11:00-11:20
- Neuroendocrine-Fat-Liver AxisLaura E. Nagy (Cleveland Clinic, USA)
- 11:20-11:40
- Lymphatic System and Organ CrosstalkYasuko Iwakiri (Yale Univ., USA)
- 11:40-12:00
- Liver-Lung CrosstalkGavin E. Arteel (Univ. of Pittsburgh, USA)
- 12:00-12:20
- Glutamate/mGluR5-mediated Endocannabinoid in Alcoholic Fatty LiverWon-IL Jeong (KAIST)
- 12:20-12:30
- CYP2E1 Regulation of Ethanol-Induced Intestinal miRNAs in Liver InjuryJe-Hyun Yoon (Medical Univ. of South Carolina, USA)
- 12:30-12:40
- Chronic Alcohol Consumption Alters the Phenotype of F4/80+CD11b+ Bone Marrow Cells by Neuro-Metabolic Signaling PathwayYoung-Ri Shim (KAIST)
- 12:40-13:00
- Round Table Discussions
- 11:30-12:00
- State-of-the-Art Lecture
- Seung Woon Paik (Sungkyunkwan Univ.)
- Past, Present, and Future of Precision Hepatology: Where Do We Need to Go?W. Ray Kim (Stanford Univ., USA)
- 11:30-12:40
- PG2. Current Issues in Chronic Hepatitis C
- 11:30-11:40
- Case Presentation and Key QuestionsHyun Woong Lee (Yonsei Univ.)
- 11:40-12:00
- Retreatment Options for Chronic Hepatitis C after Oral Direct-Acting Antiviral Agent FailureJung Hyun Kwon (The Catholic Univ. of Korea)
- 12:00-12:20
- Risks and Benefits of Oral Direct-Acting Antiviral Agent Therapy in Patients with Hepatitis C Virus-Related Hepatocellular CarcinomaNae-Yun Heo (Inje Univ.)
- 12:20-12:40
- Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients Who Achieved Sustained Virological Response Yun Bin Lee (Seoul National Univ.)
- 12:10-12:55
- Satellite Symposium 1 Bayer
- 12:40-13:25
- Satellite Symposium 2 Gilead
- 13:00-13:45
- Satellite Symposium 3 AbbVie
- 13:00-14:30
Real Time Discussion
KLCA Symposium 1. The Changing Landscape and New Evidences in Treatment Strategies for Hepatocellular Carcinoma- Joong-Won Park (National Cancer Center Korea), Jung-Hwan Yoon (Seoul National Univ.)
- 13:00-13:20
- Current Evidences and Future Perspectives for the Treatment of Advanced Hepatocellular CarcinomaJeong Won Jang (The Catholic Univ. of Korea)
- 13:20-13:40
- When Should We Consider Systemic Therapy in BCLC Stage B Hepatocellular Carcinoma?Hyung Joon Yim (Korea Univ.)
- 13:40-14:00
- Therapeutic Efficacy of Transarterial-Based Treatment vs. Targeted Therapy in Advanced Hepatocellular CarcinomaSadahisa Ogasawara (Chiba Univ., Japan)
- 14:00-14:20
- Optimizing Therapeutic Efficacy with Systemic Treatment and Radiotherapy in Hepatocellular CarcinomaJinsil Seong (Yonsei Univ.)
- 14:20-14:30
- Discussion
- 13:30-14:40
- PG3. Consensus on the Management of Nonalcoholic Fatty Liver Disease
- 13:30-13:40
- Case Presentation and Key Questions Young-Joo Jin (Inha Univ.)
- 13:40-14:00
- Assessment of Co-Morbidities in Patients with Nonalcoholic Fatty Liver DiseaseJung Il Lee (Yonsei Univ.)
- 14:00-14:20
- Pathogenesis and Management of Non-Obese Nonalcoholic Fatty Liver DiseaseHwi Young Kim (Ewha Womans Univ.)
- 14:20-14:40
- Currently Available Treatment Strategy in Patients with Nonalcoholic Steatohepatitis and Metabolic SyndromeWon Sohn (Sungkyunkwan Univ.)
- 14:00-15:10
Real Time Discussion
General Oral Presentation 1- Myung Seok Lee (Hallym Univ.), Byung Ik Kim (Sungkyunkwan Univ.)
- 14:40-15:50
Real Time Discussion
LCGSJ-KLCA Joint Symposium. Similarities and Differences in HCC Management- Shoji Kubo (Osaka City Univ., Japan), Jin Wook Chung (Seoul National Univ.)
- 14:40-14:55
- Current Approaches to the Treatment of Early HCC in JapanShuichiro Shiina (Juntendo Univ., Japan)
- 14:55-15:10
- Current Approaches to the Treatment of Early HCC in KoreaMyeong Jun Song (The Catholic Univ. of Korea)
- 15:10-15:25
- Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Japanese ExperienceHideyuki Sakurai (Univ. of Tsukuba, Japan)
- 15:25-15:40
- Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Korean ExperienceHee Chul Park (Sungkyunkwan Univ.)
- 15:40-15:50
- Discussion
- 14:50-16:00
- PG4. Assessment and Management of Liver Cirrhosis Complications
- 14:50-15:00
- Case Presentation and Key Questions Young-Joo Jin (Inha Univ.)
- 15:00-15:20
- How to Assess Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis?Eileen L. Yoon (Inje Univ.)
- 15:20-15:40
- When and How to Use Anticoagulants for Benign Portal Vein Thrombosis in Patients with Liver CirrhosisYoung Kul Jung (Korea Univ.)
- 15:40-16:00
- Update of Beta Blocker and Albumin Use for Patients with Decompensated Liver CirrhosisKi Tae Yoon (Pusan National Univ.)
- 15:10-18:10
- Abdominal Ultrasonography Training Course for Certified Trainer
- 15:10-15:30
- Introduction to Ultrasonography Training Program for Trainer and Trainee of KASLMoon-Young Kim (Yonsei Univ. Wonju)
- 15:30-15:50
- Useful Tips for Setting-up of Ultrasound RoomsSoo Young Park (Kyungpook National Univ.)
- 15:50-16:10
- Experience of Ultrasonography Education Programs for Residents and Fellows in KoreaJun Yong Park (Yonsei Univ.)
- 16:10-16:30
- Tips for Ultrasonography Examination in Patients with Poor Sonographic WindowJaeyoun Cheong (Ajou Univ.)
- 16:30-16:50
- Contrast-enhanced Ultrasonography in the Diagnosis of Focal Liver LesionsSae Hwan Lee (Soonchunhyang Univ.)
- 16:50-17:10
- Ultrasonography-guided Procedures: Percutaneous Drainage Insertion and Liver Biopsy Seung Whan Cha (Yonsei Univ. Wonju)
- 17:10-17:30
- Clinical Application of Liver Stiffness and Viscosity Measurement Using Shear Wave ElastographySang Gyune Kim (Soonchunhyang Univ.)
- 17:30-17:50
- Technological advancement in Ultrasonography: Real-Time Fusion Imaging of Liver Ultrasonography with CT or MRI Ji Young Kwon (Canon Medical Systems)
- 17:50-18:10
- Comparison Between Transabdominal Ultrasonography and Endoscopic Ultrasonography for the Diagnosis of Pancreaticobiliary DiseaseYoung Koog Cheon (Konkuk Univ.)
- 16:00-17:30
Real Time Discussion
KASL Symposium 2. New Insights to Unanswered Issues in Treatment for Chronic Hepatitis B- Seung Kew Yoon (The Catholic Univ. of Korea), Kyun-Hwan Kim (Sungkyunkwan Univ.)
- 16:00-16:20
- Exploring Unrecognized Risks in Immune Tolerant Phase of Chronic Hepatitis BYoung-Suk Lim (Univ. of Ulsan)
- 16:20-16:40
- Clonal Hepatocyte Expansion and Hepatitis B Virus IntegrationPatrick Kennedy (Queen Mary Univ. of London, UK)
- 16:40-17:00
- Effect of Current and Novel Antivirals on the Prevention of Hepatocellular Carcinoma: Beyond Viral SuppressionGeorge V. Papatheodoridis (National and Kapodistrian Univ. of Athens, Greece)
- 17:00-17:20
- Functional Cure of Chronic Hepatitis B and BeyondMan-Fung Yuen (The Univ. of Hong Kong, Hong Kong)
- 17:20-17:30
- Discussion
- 16:10-17:30
- PG for Basic Research
- 16:10-16:30
- Assessment of Mitochondrial Function in Liver ResearchHyon-Seung Yi (Chungnam National Univ.)
- 16:30-16:50
- Selection and Utilization of Murine Models in Liver ResearchSeung-Jin Kim (Kangwon National Univ.)
- 16:50-17:10
- Basic Understanding of Genomics and Proteomics StudyJu-Seog Lee (MD Anderson Cancer Center, USA)
- 17:10-17:30
- A Noble and Powerful Tool: Single Cell RNA SequencingYoung Seok Ju (KAIST)